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Abstract. Catheter-associated urinary tract infections (CAUTIs) occur frequently in healthcare settings. The
insertion and maintenance of indwelling urinary catheters is a routine element of healthcare. In order to prevent
CAUTI, it is important that healthcare professionals providing catheter care understand the indications for catheter use
and the correct procedure for insertion and maintenance of catheters. This paper reviews and summarises three recent
key publications on the prevention of CAUTIs and proposes the use of a care bundle and checklist for catheter
indications, insertion and maintenance, and quality improvement.
Process of position statement development
The Tasmanian Infection Prevention and Control Unit
(TIPCU) examined and synthesised three catheter-associated
urinary tract infections (CAUTI) reviews in the current
literature. From this process a checklist/care bundle was
developed. Substantial input was then received from the
Australasian Society for Infectious Disease (ASID)members,
including members of the ASID Healthcare Infection Control
Special Interest Group (HICSIG), and theAustralian Infection
Control Association (AICA). The authors responded to all
comments received.
Background
Catheter-associated urinary tract infections (CAUTIs) are
common in healthcare settings. Around 20%of all healthcare-
associated infections are urinary tract infections,1 and most of
these are associated with some form of instrumentation of the
urinary tract.2
Between 15% and 25% of hospitalised patients receive
a short-term indwelling urinary catheter.3–6 The duration of
catheterisation is themost important risk factor fordevelopment
of infection,7 while additional risk factors include female sex,
older age and not maintaining a closed drainage system.8
The limitations and heterogeneity of definitions used in
various studies present major challenges to defining clinical
and surveillance definitions of CAUTI.2 The three articles
reviewed in this paper do not provide definitions, but rather
defer to National Healthcare Safety Network9 (NHSN)
definitions, or in the case of Tenke et al. (2009) definitions
are not discussed. NHSN definitions were recently revised
and now provide additional clarity and uniformity in the
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distinguishing of asymptomatic and symptomatic CAUTI
and the time period for follow-up surveillance following
catheter removal.2
Most microorganisms causing CAUTI derive from the
patient’s own colonic and perineal flora or from the hands of
healthcare workers.10,11 Bacteria can enter the urinary tract
at the time of catheter insertion via the catheter tip or
subsequently once the patient is catheterised via the
extraluminal or intraluminal route. Common inoculation
source-sites include the catheter tip, when the perineum and
distal urethra are inadequately cleaned;12 the taps of the
drainage bag which afford bacteria access to the catheter and
eventually the bladder;7 and residual urine remaining in the
collection bag, which acts as a focus for organisms to spread
via the intraluminal route.12 While infections may arise via
the intraluminal route when a closed system is not maintained
or the collection bag is contaminated, it is believed that the
majority of infections arise from extraluminal (via the outside
of the catheter) bacterial migration.10
To reduce the risk of CAUTI, there is a need to develop and
implement a range of prevention measures. Over the past
2 years, three major publications have reviewed the literature
and developed recommendations on the prevention of
CAUTIs, namely:
* European and Asian Guidelines on management and
prevention of catheter-associated urinary tract infections;7
* Strategies to Prevent Catheter-Associated Urinary
Tract Infections in Acute Care Hospitals Practice
Recommendation, Society for Healthcare Epidemiology
of America (SHEA) and Infectious Diseases Society of
America;8
* Guidelines for Prevention of Catheter-Associated Urinary
Tract Infections 2010, Healthcare Infection Control
Practices Advisory Committee (HICPAC).2
The purpose of this paper is to propose a clear approach
to the prevention of CAUTIs for adoption across Australia
applicable to all healthcare settings including residential
and aged care. The approach described is consistent with an
Australian context, using recommendations from the
publications described above and the NHMRC Australian
Guidelines for the Prevention and Control of Infection in
Healthcare.13 A suggested checklist has also been developed
for the insertion of indwelling urinary catheters.
Recommendations
Practices to minimise the risk of CAUTIs can be summarised
into three distinct areas: insertion, maintenance and quality
improvement. This paper provides recommendations
supported by the literature in each of these areas. A summary
of key recommendations, including their grading, are detailed
in Tables 1 and 2.
Table 1. Summary of key graded recommendations and the level of evidence supporting them as used in the major CAUTI review papers
Recommendation EPIC (2007)24 HICPAC (2010)2 European (2008)7 SHEA/IDSA (2009)8
Y/N Grade Y/N Grade Y/N Grade Y/N Grade
Catheter indications
Evaluate necessity Y Class D Y 1A Y x Y A
Alternative methods ND Y 1B Y x Y AI
Insertion
Documentation of insertion Y Class D Y II Y B Y AII
Trained staff Y Class D Y 1C ND x Y BIII
Train patients/family Y Class D Y 1C ND x Y AIII
Hand hygiene ND (implicit) x Y 1B Y A Y A
Select catheter material ND x ND x ND (directly) x ND x
Smallest gauge Y Class D Y II Y B Y BIII
Aseptic/sterile technique Y Class D Y 1C Y B Y AIII
Barrier precautions for insertion ND x Y 1C ND x Y AIII
Antiseptic cleaning of meatus N Class D N 1B N A N AI
Review ongoing need/time minimal Y Class D Y 1B Y A Y A
Maintenance
Use closed system Y Class A Y 1B Y A Y AI
Urine samples aseptically Y Class D Y 1C ND x Y AIII
Replace if break in asepsis ND x ND x ND x ND x
Do not change catheter routinely Y Class D Y 1B Y B Y AII
Perform routine meatus care Y Class A Y 1B ND x Y AI
Avoid irrigation Y Class A Y 1B ND x Y AI
Cohort patients ND Y II ND x ND x
Quality improvement
Compliance with training ND x ND x ND x ND x
Compliance with control ND x Y as below x Y as below x Y as below x
Compliance with removal ND x Y as below x Y as below x Y as below x
Monitor rates ND x Y II ND Y AII
ND, not discussed.
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Insertion
The first and foremost goal of CAUTI prevention is a
reduction in the overall use of indwelling catheters, especially
in those at high risk of complications from CAUTIs. Those
at high risk include women, the elderly and patients with
impaired immunity, severe underlying illness, diabetes,
renal dysfunction or incontinence.2 Wherever possible,
alternatives, such as suprapubic catheters, condom drainage
systems or intermittent catheterisation should always be
considered where appropriate.2,7 To assist in this process,
there is a need to establish clear indications for the use of
indwelling catheters, as summarised in Table 3. Low quality
evidence suggested a benefit of alternative catherisation
methods in selected population groups.2
When inserting a urethral catheter, the correct procedure
must be followed to mimimise the risk of introducing bacteria
into the bladder. Recommendations relating to the insertion of
indwelling catheters are summarised as follows.
Table 2. Summary of grading systems used
IDSA/SHEA Practice Recommendations
Strength
A – Good evidence to support a recommendation for use.
B – Moderate evidence to support a recommendation for use.
C – Poor evidence to support a recommendation.
Quality
I – Evidence from >1 properly randomised, controlled trial.
II – Evidence from >1 well designed clinical trial, without randomisation; from cohort or case-control analytic studies (preferably from >1 centre), frommultiple
time series; or from dramatic results from uncontrolled experiments.
III – Evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.
HICPAC Guidelines
Category IA – Strongly recommended for implementation and supported by well-designed experimental, clinical or epidemiologic studies.
Category IB – Strongly recommended for implementation and supported by certain experimental, clinical or epidemiologic studies and a strong theoretical
rationale.
Category IC – Required by state or federal regulation or representative of an established standard for which data are not available.
Category II – Suggested for implementation and supported by suggestive clinical or epidemiologic studies or a theoretical rationale.
No recommendation – Unresolved issue; practices for which insufficient evidence or no consensus regarding efficacy exist.
European & Asian Guideline
Level of evidence
Ia – Evidence obtained from meta-analysis of randomised trials.
Ib – Evidence obtained from at least one randomised trial.
IIa – Evidence obtained from one well-designed, controlled study without randomisation.
IIb – Evidence obtained from at least one other type of well-designed, quasi-experimental study.
III – Evidence obtained from well-designed, non-experimental studies such as comparative studies, correlation studies and case reports.
IV – Evidence obtained from expert committee reports or opinions or clinical experience of respected authorities.
Grade of guideline recommendation
A – Based on clinical studies of good quality and consistency addressing the special recommendations and including at least one randomised trial.
B – Based on well-conducted clinical studies, but without randomised clinical trials.
C – Made despite the absence of directly applicable clinical studies of good quality.
EPIC 2 Guidelines
Level of evidence
1++ High-quality meta-analyses, systematic reviews of randomised controlled trials (RCT), or RCT with a very low risk of bias.
1+ Well-conducted meta-analyses, systematic reviews of RCT, or RCT with a low risk of bias.
1 – Meta-analyses, systematic reviews of RCT, or RCT with a high risk of bias.
2++ High-quality systematic reviews of case-control or cohort studies. High-quality case-control or cohort studies with a very low risk of confounding, bias
or chance and a high probability that the relationship is causal.
2+ Well conducted case-control or cohort studies with a low risk of confounding, bias or chance and a moderate probability that the relationship is causal.
2 – Case-control or cohort studies with a high risk of confounding bias, or chance and a significant risk that the relationship is not causal.
3 – Non-analytic studies (for example, case reports, case series).
4 – Expert opinion, formal consensus.
Class A – Systematic review of RCT or a body of evidence that consists principally of studies rated as 1+, is directly applicable to the target population
and demonstrates overall consistency of results. Evidence drawn from a National Institute of Clinical Excellence technology appraisal.
B – A body of evidence that includes studies rated as 2++, is directly applicable to the target population and demonstrates overall consistency of results, or
Extrapolated evidence from studies rated as 1++ or 1+.
C – A body of evidence that includes studies rated as 2+, is directly applicable to the target population and demonstrates overall consistency of results, or
Extrapolated evidence from studies rated as 2++.
D – Evidence level 3 or 4, or
Extrapolated evidence from studies rated as 2+, or
Formal consensus. D (GPP). A good practice point (GPP) is a recommendation.
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* Provide and follow written guidelines for catheter use,
insertion and maintenance.8
* Consider the use of a portable ultrasound device to assess
urine volume in patients undergoing intermittent
catheterisation.2,8
* Implement a system for documenting the following
information in the patient record: indications for catheter
insertion, date and time of catheter insertion, details of the
individual who inserted catheter, and date and time of
catheter removal.8
* Ensure that only trained, competent personnel insert urinary
catheters.8 This may include hospital personnel, family
members, or patients themselves who know the correct
technique of aseptic catheter insertion and maintenance.2
* Perform hand hygiene immediately before insertion of the
catheter.2,8
* Clean (i.e. non-sterile) equipment is appropriate for chronic
intermittent catheterisation in a non-acute care setting.7,14,15
* Insert an indwelling catheter using an aseptic non-touch
technique, using sterile equipment. Equipment required
includes: sterile gloves, a drape, sterile swabs, a sterile
solution for cleaning the urethral meatus, and a single-use
packet of sterile lubricant jelly for insertion.2,8,13 Antiseptic
lubricants need not be used routinely to prevent
CAUTI.13,14 While there is very low-quality evidence
suggesting a reduced risk of CAUTI from using lubricants
during catheter insertion, several studies have found no
significant difference between antiseptic lubricants and
non-antiseptic lubricants in preventing CAUTI.2
* Use the smallest catheter as possible, consistent with proper
drainage, to minimise urethral trauma.2, 8
* Do not use antibiotic-impregnated catheters routinely as
there is no evidence that they decrease symptomatic
infection.7
* Donot use systemic antimicrobials routinely as prophylaxis
inpatients requiring either short or long-termcatheterisation
unless indications exist.2,8 There are studies suggesting
the incidence of catheter-associated bacteruria may be
reduced by antimicrobial prophylaxis;11,16 however, this
protective effect is transient (lasts only a few days) and is
associated with the selection of resistant organisms.
Prophylaxis is not indicated for patients at low risk for
acquired bacteruria and in whom the sequelae of catheter-
associated infections are infrequent.16
* Urinary catheter systems with pre-connected, sealed
catheter-tubing junctions may reduce the risk of CAUTI
compared with unsealed catheter systems.2
Maintenance
The following suite of strategies relating to the maintenance
of a catheter will aid in the reduction of infection risk.
* Properly secure indwelling catheters after insertion to
prevent movement and urethral traction.2,8
* Perform hand hygiene before and after any manipulation
of the catheter site or apparatus,2,8 consistent with the ‘five
moments’ of hand hygiene.17
* Use standard precautions as appropriate during any
manipulation of the catheter or collecting system.2
* The catheter must be maintained as a sterile, continuously
closed drainage system, with unobstructed urine flow.2,7,8
* Do not disconnect the catheter and drainage tube unless the
catheter has to be irrigated.
* Keep the collecting bag below the level of the bladder at all
times, but do not rest the bag on the floor.2,8, 13
* If breaks in aseptic non-touch technique, disconnection,
or leakage occur, replace the catheter and collecting
system using aseptic non-touch technique and sterile
equipment.2,8
* Avoid catheter irrigation if possible, and do not perform
continuous irrigation of the bladder with antimicrobials as
a routine infection prevention measure. If obstruction is
anticipated, closed continuous irrigation may be used to
prevent it. To relieve obstruction due to clots, mucus or
other causes, an intermittent method of irrigation may be
used.8
* The use of topical antiseptics or antibiotics applied to the
catheter, urethra or meatus is not recommended;7 routine
hygiene is adequate.13
* Chronic antibiotic suppressive therapy is generally not
recommended.7
Table 3. Indications for indwelling catheter use
a) Patient has acute urinary retention or obstruction
b) Urinary output monitoring in critically ill patients
c) Peri-operative use for selective surgical procedures†
* Urological surgery or surgery involving other contiguous structures of genitourinary tract
* Prolonged duration of surgery (removed in recovery)
* Large volumes of infusions or diuretics administered intra-operatively
* Operative patients with urinary incontinence
* Need for intraoperative monitoring of output
d) Healing of wounds (sacral/perianal) in incontinent patients (as part of a holistic plan)
Patient
e) Patient requiring prolonged immobilisation (e.g. potentially unstable thoracic or lumbar spine, multiple traumatic injuries such as pelvic fractures)z
f) Exceptional circumstances, e.g. comfort at end of life
†In these settings the catheter should be removed within 24 h post-operatively where possible.
zAvoid using indwelling urinary catheters for the management of incontinence. This includes residential aged care residents.
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* For examination of fresh urine, a small sample should be
collected by aspirating urine from the sampling port with a
sterile needle and syringe after cleansing the port with
disinfectant.2,8 Obtain larger volumes of urine for special
analyses (not culture) aseptically from the drainage bag.2,8
* Do not screen for asymptomatic bacteruria (ASB) in
catheterised patients using a dipstick or a laboratory test
(M&C&S) (note that ASB is no longer included in the
NHSN surveillance definitions for UTI).2,8
* Do not treat ASB in catheterised patients except before
invasive urologic procedures.8
* Do not change short-term catheters routinely.2,8
* Long-term indwelling catheters should be changed at
intervals adapted to the individual patient.7 There is
insufficient evidence to support the practice of changing
catheters atfixed intervals.7 It is suggested therefore, that the
decision to change catheters and drainage bags should be
based on clinical indications such as infection, obstruction
or a break in the closed system.2
* Clamping indwelling catheters before removal is
unnecessary.2,13
* Minimise the duration of catheterisation; that is,
catheterisation should be only for as long as indications
exist.2,7,8
Quality improvement
Positioning CAUTI prevention strategies within an infection
prevention and control framework allows for targeted
monitoring, assessment and evaluation of interventions.
Furthermore, it requires the identification of responsibilities
and roles for addressing the prevention of CAUTIs. Under
the umbrella of quality improvement, the following
recommendations provide guidance to organisations to reduce
the risk of CAUTI.
1. A hospital or healthcare organisations’ Chief Executive
Officer and senior management should be responsible for
ensuring that the healthcare system supports an infection
prevention and control program and that this program
reduces the risks of CAUTI and the transmission of
epidemiologically significant pathogens.8 An infection
control program should include the provision of
education about CAUTI, other complications of urinary
catheterisation and alternatives to indwelling catheters.2,8
2. Healthcare organisations should consider implementing
quality improvement (QI) programs to enhance
appropriate use of indwelling catheters and to reduce the
risk of CAUTI.2 Such QI programs could include
the development and implementation of institutional
policies requiring continual (daily) review of the need for
continued catheterisation.8 Electronic or other types of
reminders may be useful in assisting in complying with
such a recommendation. Examples of strategies to
monitor the continued need for urinary catheters include:
automatic stop orders requiring renewal of the order for
continuation of the indwelling catheter; standardised
reminders placed into the patient record; and daily ward
rounds by clinical staff to review all patients with urinary
catheters and to ascertain continuing necessity of the
catheter.8
3. Asurveillanceprogram(either process or outcome)would
assist in monitoring the rates of urinary tract infections.
Such aprogramcould be developedbasedon a facility risk
assessment.2 Examples of programs related to CAUTI
surveillance and QI could include the establishment of a
system for analysing and reporting data on catheter use
and adverse events from the catheter, including
stratification by relevant risk factors (e.g. sex, age, ward
and duration).2,8
Unresolved issues
Either a lack of compelling evidence or a limited number of
studies make it difficult to form recommendations addressing
several clinical and administrative aspects of catheter use. To
elicit appropriate guidance and resolve these issues, further
work is required in the following areas:
* Evidence on effect of silver alloy catheters in reducing the
risk of symptomatic and asymptomatic bacteruria has been
reported in a small number of studies.18–21 However,
reviews of catheter materials have concluded that the use of
silver alloy impregnated catheters has no significant
advantages and these are not recommended for routine use.
The question of the benefit of using other types of
antimicrobial-coated catheters remains unresolved as does
the question of identifying which catheter materials best
delay the onset of bacteruria, bacterial adherence and
bacterial growth.7,8
* The benefit of using an antiseptic solution versus the use of
sterile saline for meatal cleaning before catheter insertion
remains unresolved.2,8
* The role of periodic (e.g. night time) use of condom
catheters in incontinent male patients is unresolved.2,8
* The use of catheters to prevent skin breakdown is
unresolved.2,8
* There is limited evidence that post-operative intermittent
catheterisation reduces the risk of bacteruria comparedwith
an indwelling catheter.7
* Finally, there are no standardised surveillance measures of
CAUTI that would aid in inter-regional assessments and
external reporting.8
Suggested care bundle/checklist
To elicit a consistent and pro-active response to the guidelines
summarised here, we recommend the adoption of a care
bundle/checklist (Figs 1, 2). Primarily, this would serve as a
checklist of considerations taken to ensure catheter use is
limited. If catheterisation is indicated, the checklist provides
evidence-based guidelines to follow to reduce the risk of
acquiring a CAUTI. Secondarily, the use of a checklist
provides a source of catheter documentation, this being an
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Fig. 1. Example of a checklist for catheter insertion. This has been adapted fromaCAUTIbundle and checklist
developed by Health Protection Scotland25 and Institute for Healthcare Improvement26 and with consideration
and input from ASID/AICA.
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important step in themonitoring and analysis of CAUTIs. The
checklist could exist as a preliminary stand-alone measure
before the implementation of a more holistic institutional
policy, or as an adjunct to such a policy, such as a clinical care
pathway. Regardless of where the checklist is positioned
within institutional policy, in order to achieve holistic,
systemic improvements to the way catheter care is
administered, the checklist should be underpinned by
leadership, culture change andmeasurement.22,23 Further, the
checklist could easily be broadened to include post-insertion
information such as the onset of bacteruria, any other adverse
events resulting from catheter use and the eventual duration of
catheterisation. The checklist provided can be added to or be
modified according to organisational needs.
Summary and future work
After reviewing key publications on the prevention of
CAUTIs, it appears there is consensus on the major
recommendations and issues relating to the insertion,
maintenance and quality improvement practices needed to
reduce the incidence of CAUTIs. This AICA/ASID position
statement reflects these recommendations. One of the key
principles in the prevention of CAUTIs is to minimise
both the number of indwelling catheters inserted and also
the duration of catheterisation of individuals. Quality
improvement activities form a fundamental part of CAUTI
prevention, with one key QI activity being surveillance. The
issue of CAUTI surveillance is an area that particularly
requires further work and exploration, and the AICA and
ASID would encourage this work to occur.
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